Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Rev. calid. asist ; 27(3): 169-174, mayo-jun. 2012.
Artigo em Inglês | IBECS | ID: ibc-100294

RESUMO

Objetivo. Conocer la incidencia de prescripciones potencialmente inapropiadas (PPI) de los pacientes mayores de 65 años ingresados en las unidades de neumología y cardiología, así como los fármacos principalmente implicados y su severidad clínica. Métodos. Estudio observacional, prospectivo, de 6 meses de duración. Se revisaron los tratamientos de los pacientes mayores de 65 años ingresados en estas unidades. Se consideraron como PPI las incluidas en la lista de Beers de 2003. Se recogió la unidad clínica, edad, sexo, fármaco inapropiado, dosis y vía de administración. Se calculó la incidencia de PPI (número de PPI/número de pacientes) global y en función la unidad clínica, así como según el sexo, fármaco implicado y severidad clínica. Resultados. Se recogieron datos de 385 pacientes (190 en cardiología y 195 en neumología). Se encontraron 111 PPI (0,29 PPI/paciente). Teniendo en cuenta la unidad de origen, se encontraron 53 PPI en cardiología (0,28 PPI/paciente) y 58 PPI en neumología (0,30 PPI/paciente). El 66,6% (n=74) de las PPI ocurrieron en hombres y el 33,4% (n=37) en mujeres. Los principales fármacos implicados fueron amiodarona (24,3%), digoxina (19,8%), doxazosina (17,1%) y diazepam (16,2%). El 68,5% de las PPI encontradas fueron de severidad alta según los criterios de Beers. Conclusión. La prescripción de medicamentos inapropiados en ancianos es elevada. Esto es importante ya que son una de las causas de aparición de reacciones adversas a medicamentos, las cuales provocan a su vez una parte importante de los ingresos hospitalarios. La inclusión de alertas en el programa de prescripción asistida y la difusión de boletines informativos al respecto en el personal implicado mejoraría la calidad de la asistencia sanitaria y minimizaría los problemas relacionados con la medicación(AU)


Objective. To determine the incidence of potentially inappropriate prescriptions (PPI) for patients older than 65 years admitted to the cardiology and respiratory medicine units, as well as the main drugs involved and their clinical severity. Methods. A prospective, observational study was carried out over a 6 month period. We reviewed the treatment of patients over 65 years old admitted to these units. PPI is considered as those included in the Beers criteria 2003. We recorded clinical unit, age, sex, inappropriate drug, dosage and route of administration. We calculated the overall incidence of PPI (number of PPI/number of patients) and according to the clinical unit, sex, drug involved, and clinical severity. Results. Data were collected from 385 patients (190 in cardiology and 195 respiratory medicine unit). We found 111 PPI (0.29 PPI/patient). If we take into account the clinical unit, there were 53 PPI in cardiology (0.28 PPI/patient) and 58 PPI in respiratory medicine (0.30 PPI/patient). Two-thirds (66.6%, n=74) of the PPI occurred in men and 33.4% (n=37) in women. The main drugs involved were amiodarone (24.3%), digoxin (19.8%), doxazosin (17.1%) and diazepam (16.2%). According to the Beers criteria, 68.5% of those were high severity PPI. Conclusion. The prescription of inappropriate medications in the elderly is high. This is important because they are a cause of adverse reactions, which leads to a significant proportion of hospital admissions. The inclusion of warnings in the program of assisted prescribing and distributing of newsletters about these to the personnel involved, improves the quality of health care and minimises medication-related problems(AU)


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Prescrição Inadequada/classificação , Prescrição Inadequada/ética , Prescrição Inadequada/estatística & dados numéricos , Serviço Hospitalar de Cardiologia/economia , Serviço Hospitalar de Cardiologia/organização & administração , Unidades de Cuidados Respiratórios/economia , Unidades de Cuidados Respiratórios/estatística & dados numéricos , Digoxina/uso terapêutico , Prescrição Inadequada/legislação & jurisprudência , Prescrição Inadequada/prevenção & controle , Serviço Hospitalar de Cardiologia/normas , Estudos Prospectivos
2.
Rev Calid Asist ; 27(3): 169-74, 2012.
Artigo em Espanhol | MEDLINE | ID: mdl-22178634

RESUMO

OBJECTIVE: To determine the incidence of potentially inappropriate prescriptions (PPI) for patients older than 65 years admitted to the cardiology and respiratory medicine units, as well as the main drugs involved and their clinical severity. METHODS: A prospective, observational study was carried out over a 6 month period. We reviewed the treatment of patients over 65 years old admitted to these units. PPI is considered as those included in the Beers criteria 2003. We recorded clinical unit, age, sex, inappropriate drug, dosage and route of administration. We calculated the overall incidence of PPI (number of PPI/number of patients) and according to the clinical unit, sex, drug involved, and clinical severity. RESULTS: Data were collected from 385 patients (190 in cardiology and 195 respiratory medicine unit). We found 111 PPI (0.29 PPI/patient). If we take into account the clinical unit, there were 53 PPI in cardiology (0.28 PPI/patient) and 58 PPI in respiratory medicine (0.30 PPI/patient). Two-thirds (66.6%, n=74) of the PPI occurred in men and 33.4% (n=37) in women. The main drugs involved were amiodarone (24.3%), digoxin (19.8%), doxazosin (17.1%) and diazepam (16.2%). According to the Beers criteria, 68.5% of those were high severity PPI. CONCLUSION: The prescription of inappropriate medications in the elderly is high. This is important because they are a cause of adverse reactions, which leads to a significant proportion of hospital admissions. The inclusion of warnings in the program of assisted prescribing and distributing of newsletters about these to the personnel involved, improves the quality of health care and minimises medication-related problems.


Assuntos
Cardiologia , Unidades Hospitalares , Prescrição Inadequada/estatística & dados numéricos , Pneumologia , Idoso , Feminino , Humanos , Masculino , Estudos Prospectivos
3.
Ars pharm ; 52(3): 46-57, jul.-sept. 2011. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-92323

RESUMO

La utilización de terapias basadas en anticuerpos monoclonales ha supuesto un gran avance en la práctica clínica. Tienen un ámbito de utilización muy diverso, incluyendo aplicaciones diagnósticas y terapéuticas principalmente. En cuanto a su uso como tratamiento, las áreas más beneficiadas con su descubrimiento han sido la oncología y las enfermedades del sistema inmune.Se trata de un área en continuo crecimiento, tanto por la aparición de nuevos fármacos, como por la ampliación de indicaciones de los ya existentes. Esta revisión resume las características farmacológicas más importantes de los anticuerpos monoclonales comercializados en nuestro país. Se centra principalmente en la utilidad terapeútica, dosificación, eventos adversos de gran relevancia clínica y consideraciones importantes para su correcta administración. También se realiza un breve apunte de las indicaciones de los anticuerpos monoclonales autorizados por la agencia europea del medicamento (EMEA) y que se encuentran en distintas fases del proceso de comercialización(AU)


The utilization of therapies based on monoclonal antibodies has supposed a great advance in the clinical practice. They have a diverse field of use, including diagnostic and therapeutic applications. As treatment, the most benefited has been the oncology and immune system diseases.This is an area in continuous growth, so much for the appearance of new medicaments, since for the extension of indications of the already existing ones. This review summarizes the most important pharmacological characteristics of the monoclonal antibodies commercialized in our country. It centres principally on the authorized indications, dosing, adverse events of great clinical relevancy and important considerations for his correct administration. Also there is realized a brief note of the indications of the monoclonal antibodies authorized by the European agency of the medicine (EMEA) and that are in different phases of the process of commercialization(AU)


Assuntos
Humanos , Anticorpos Monoclonais/uso terapêutico , Doenças do Sistema Imunitário/tratamento farmacológico , Neoplasias/tratamento farmacológico , Anticorpos Monoclonais/farmacologia
4.
SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. impr.) ; 36(8): 471-476, oct. 2010. ilus
Artigo em Espanhol | IBECS | ID: ibc-82122

RESUMO

El aneurisma de aorta abdominal es una dilatación patológica de la aorta infrarrenal, con un diámetro anteroposterior mayor o igual a 3cm. La población de más riesgo son los varones fumadores, de edad avanzada y con historia familiar aneurismática. La ecografía abdominal es un método sensible, específico y rentable para el diagnóstico de dicha enfermedad y la cirugía electiva sobre el aneurisma permite una disminución en la morbimortalidad por esta causa. Presentamos 3 pacientes con criterios de riesgo, atendidos en una consulta de medicina de familia y a quienes se les practicó una ecografía abdominal por diferentes motivos, a través de la cual se realizó el diagnóstico de aneurisma de aorta abdominal. Dos de ellos están actualmente en seguimiento, otro fue intervenido y murió en el postoperatorio. Planteamos así la pertinencia del cribado del aneurisma de aorta abdominal, mediante ecografía en atención primaria, en población de riesgo (AU)


Abdominal aortic aneurysm is an abnormal dilatation of the infrarenal portion of the aorta, with an anteroposterior diameter equal to or greater than 3cm. The population at greatest risk includes older males, with an aneurysmal family history and smokers. The abdominal ultrasound scan is a sensitive, specific and profitable method to diagnose the disease and programmed surgery of the aneurysm makes it possible to reduce the morbidity and mortality due to it. We present the cases of three patients with abdominal aortic aneurysm risk criteria who were attended in Primary Care. All of them had abdominal ultrasound scans for different reasons and were diagnosed with aortic aneurysm. Two of them are currently being monitored. The third patient, who was operated on, died during the postoperative care. In this way, we propose the importance of screening for abdominal aortic aneurysms using the abdominal ultrasound scan in Primary Care for the at risk population (AU)


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Aneurisma da Aorta Abdominal/diagnóstico , Atenção Primária à Saúde/métodos , Programas de Rastreamento/métodos , Fatores de Risco , Aneurisma da Aorta Abdominal , Abdome/patologia , Abdome , Análise Custo-Eficiência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...